2021 GA Meeting May 12th, 14:00-15:30



The 2020 GA meeting which normally takes place in May was postponed to November 4th due to the global pandemic. The November 4th meeting which was virtual saw 20 attendees and lasted an hour as most of the GA mandated task/decisions were addressed by way of votes prior to the meeting. Chaired by Interim Chairman Dr Bernd Friede, the meeting though brief was effective with some key decisions taken as follows:

Some highlights:

  • Executive Committee: A new Executive team was endorsed with the 2nd Vice-Chairman becoming the Chairman and Secretary General maintained to ensure continuity
  • Non-EU letter of Access Fees: Letter of Access fees and administration fees for non-EU REACH-Like regulations per substance, per legal entity for non-MARA members was established
  • Members involvement in Non-EU regulations: MARA members wishing to register substances in non-EU REACH-like regulations will only pay administration fees as they own the data generated by MARA
  • Technical update: Three dossiers updated this year lead to a new classification for manganese based UVCB’s
  • 2020 Workplan and budget were ratified in Q1, 2020 via round robin votes.
Substance Information Exchange Fora (SIEF)

Substance Information Exchange Fora (SIEF)

Substance Information Exchange Fora (SIEF)

What is a SIEF?

Under REACH, a SIEF is formed for each pre-registered substance with the same identity.  SIEF participants are either potential registrants or data holders. A SIEF has no prescribed legal form, but is a forum within which to share data, facilitate the registration process. and agree on classification and labelling (C&L) of the substance. Participants in a SIEF are free to organise themselves as they see fit (e.g. by means of a consortium or some other form of co-operation) in order to fulfil their individual REACH obligations. All SIEFs will remain operational until 1 June 2018.

A SIEF is only formed when pre-registrants have agreed that they manufacture or import the same substance. The pre-registrants will share and assess data and prepare common parts of the registration (joint submission).


What must I do?

All SIEF participants shall:

  • Request missing information from other participants
  • React to requests for information from other participants
  • Provide other participants with existing studies upon request
  • Collectively identify the need for further studies to comply with registration requirements
  • Make arrangements to perform any identified studies
  • Agree on classification and labelling of the substance
  • Nominate a Lead Registrant for the joint submission process (OSOR)

Third-party data holders in the SIEF who do not intend to submit a registration:

  • Must respond to a query from potential registrants if they hold related data
  • Are not entitled to request data

During March - June 2009, 2 internet-based survey forms were sent to each pre-registrant of Mn-based substances to the email address in the ECHA REACH-IT system. These surveys included:

  • Substance identity sameness agreement
  • SIEF formation
  • Lead registrant nomination
  • A request for data holders to come forward, and
  • SIEF participant's registration intention

The SFF dialogue box in REACH-IT, where available, includes results from these surveys.

About cookies on our website

Following a revised EU directive on website cookies, each company based, or doing business, in the EU is required to notify users about the cookies used on their website.

Our site uses cookies to improve your experience of certain areas of the site and to allow the use of specific functionality like social media page sharing. You may delete and block all cookies from this site, but as a result parts of the site may not work as intended.

To find out more about what cookies are, which cookies we use on this website and how to delete and block cookies, please see our Which cookies we use page.

Click on the button below to accept the use of cookies on this website (this will prevent the dialogue box from appearing on future visits)